Controversies in the cellular pharmacology of oligodeoxynucleotides

Antisense and Nucleic Acid Drug Development

Volumn 7, Issue 3, 1997, Pages 207-209

  Stein, C A ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CD11B ANTIGEN; NUCLEOTIDE BINDING PROTEIN; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

CELL COMPARTMENTALIZATION; CELL MEMBRANE; CONFERENCE PAPER; DRUG ADSORPTION; DRUG UPTAKE; INTERNALIZATION; PRIORITY JOURNAL;

EID: 0030839545     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1997.7.207     Document Type: Conference Paper

References (5)

1. BELTINGER, C., SARAGOVI, H.U., SMITH, R.M., LESAUTEUR, L., SHAH, N., DEDIONISIO, L., CHRISTENSEN, L., RAIBLE, A., JARETT, L., and GEWIRTZ, A.M. (1995). Binding, uptake and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Invest. 96, 1814-1823.
2. BENIMETSKAYA, L., LOIKE, J., KHALED, Z., WRIGHT, S., KAI, T., and STEIN, C.A. (1997). Mac-1 (CD11b/CD18) is a cell surface oligodeoxynucleotide binding protein. Nature Med. 3, 414-420.
3. BIT, R., DAVIS, D., ELLIOT, L., HARRIS, W., HILL, C., KEECH, A.E., KUMAR, H., LAWTON, G., MAW, A., NIXON, J., VESEY, D., WADSWORTH, J., and WILKINSON, S. (1993). Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction. J. Med. Chem. 36, 21-29.
4. FENSTER, S.D., WAGNER, R., FROEHLER, B.C., and CHIN, D.J. (1994). Inhibition of human immunodeficiency virus type-1 env expression by C-5 propyne oligoncleotides specific for rev response element stem loop V. Biochemistry 33, 8391-8398.
5. YAO, G.Q., CORRIAS, S., and CHENG, Y.C. (1996). Identification of two oligodeoxyribonucleotide binding proteins on plasma membranes of human cell lines. Biochem. Pharmacol. 51, 431-436.